title: Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
abstract: Donepezil, a member of the acetylcholinesterase inhibitor family, is approved for management of cognitive impairments as well as behavioral complications in patients with neurodegenerative Alzheimer's disease. Generally, donepezil is regarded as a safe medication in patients with Alzheimer's disease although there have been reports of several minor adverse events including gastrointestinal disturbances. Herein we describe a patient with Alzheimer's disease who demonstrated delirious behavior upon treatment with donepezil.
authors.affiliation: Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran ; National Drug and Poison Information Center, Deputy of Food and Drug, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Milad Clinical Research Center, Milad Hospital, Tehran, Iran.
authors.forename: Kamyar
authors.initials: K
authors.lastname: Mollazadeh-Moghaddam
authors.forename: Arsia
authors.initials: A
authors.lastname: Jamali
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Adili-Aghdam
authors.forename: Shahin
authors.initials: S
authors.lastname: Akhondzadeh
keywords: Alzheimer's disease; delirium; donepezil